secwatch / observer
8-K filed January 4, 2024, 6:59 PM ET ticker VTAK CIK 0001716621
leadership confidence high sentiment neutral materiality 0.60

Catheter Precision appoints new director John P. Francis, names David Jenkins CEO, Margrit Thomassen interim CFO

Catheter Precision, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John P. Francis

Class III director
VTAK · Catheter Precision, Inc.
Effective
2024-01-02
Filed
January 4, 2024, 6:59 PM ET
Effective January 2, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of the registrant, Catheter Precision, Inc. (the “Company”), has appointed John P. Francis to serve as a Class III director
Role change

David Jenkins

Chief Executive Officer
VTAK · Catheter Precision, Inc.
Effective
2024-01-02
Filed
January 4, 2024, 6:59 PM ET
Also as of the Effective Date, the Board has named David Jenkins Chief Executive Officer of the Company.
Departed

Susanne Meline

Director
VTAK · Catheter Precision, Inc.
Effective
2023-12-28
Successor
John P. Francis
Filed
January 4, 2024, 6:59 PM ET
His appointment fills the vacancy created by the previously reported resignation of Susanne Meline that occurred on December 28, 2023.
Departed

Steve Passey

Chief Financial Officer
VTAK · Catheter Precision, Inc.
Effective
2023-12-31
Successor
Margrit Thomassen
Filed
January 4, 2024, 6:59 PM ET
Ms. Thomassen replaces Steve Passey, whose employment was terminated on December 28, 2023, effective December 31, 2023.
Appointed (interim)

Margrit Thomassen

interim Chief Financial Officer and Secretary
VTAK · Catheter Precision, Inc.
Effective
2024-01-02
Filed
January 4, 2024, 6:59 PM ET
In addition, the Board has named Margrit Thomassen, age 53, to serve as interim Chief Financial Officer and Secretary as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John P. Francis was appointed as Class III director at Catheter Precision, Inc..

Action
appointed
Role
Class III director
Exact text from the filing
Effective January 2, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of the registrant, Catheter Precision, Inc. (the “Company”), has appointed John P. Francis to serve as a Class III director
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

David Jenkins was appointed as Chief Executive Officer at Catheter Precision, Inc..

Action
appointed
Role
Chief Executive Officer
Exact text from the filing
Also as of the Effective Date, the Board has named David Jenkins Chief Executive Officer of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.9

Susanne Meline resigned as Director at Catheter Precision, Inc..

Action
resigned
Role
Director
Exact text from the filing
His appointment fills the vacancy created by the previously reported resignation of Susanne Meline that occurred on December 28, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Steve Passey was terminated as Chief Financial Officer at Catheter Precision, Inc..

Action
terminated
Role
Chief Financial Officer
Exact text from the filing
Ms. Thomassen replaces Steve Passey, whose employment was terminated on December 28, 2023, effective December 31, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Margrit Thomassen was appointed as interim Chief Financial Officer and Secretary at Catheter Precision, Inc..

Action
appointed
Role
interim Chief Financial Officer and Secretary
Exact text from the filing
In addition, the Board has named Margrit Thomassen, age 53, to serve as interim Chief Financial Officer and Secretary as of the Effective Date.
View on SEC.gov

Catheter Precision, Inc. filing history →

Source: SEC EDGAR
accession 0001654954-24-000194
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.